you are here:

Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals

BSE Live

Aug 16, 16:01
927.70 -0.30 (-0.03%)
Volume
AVERAGE VOLUME
5-Day
26,954
10-Day
17,072
30-Day
8,548
8,585
  • Prev. Close

    928.00

  • Open Price

    928.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Aug 16, 15:57
925.95 -2.10 (-0.23%)
Volume
AVERAGE VOLUME
5-Day
1,079,029
10-Day
645,674
30-Day
394,437
455,476
  • Prev. Close

    928.05

  • Open Price

    928.05

  • Bid Price (Qty.)

    925.95 (189)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2021 2020 2019 2018 2017
Quarterly Results of Ipca Laboratories (in Rs. Cr.) Jun '22 Mar '22 Dec '21 Sep '21 Jun '21  
Net Sales/Income from operations 1,469.28 1,168.45 1,328.47 1,423.84 1,478.60  
Other Operating Income -- -- -- -- --  
Total Income From Operations 1,469.28 1,168.45 1,328.47 1,423.84 1,478.60  
EXPENDITURE  
Consumption of Raw Materials 439.73 394.69 397.79 404.42 404.08  
Purchase of Traded Goods 60.92 91.31 81.80 57.65 52.14  
Increase/Decrease in Stocks 15.91 -132.75 -44.06 14.08 41.97  
Power & Fuel -- -- -- -- --  
Employees Cost 297.67 272.27 260.08 276.64 280.64  
depreciat 53.41 52.39 51.25 50.50 49.96  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 397.60 363.91 321.34 312.03 305.79  
P/L Before Other Inc. , Int., Excpt. Items & Tax 204.04 126.63 260.27 308.52 344.02  
Other Income 18.81 14.21 13.24 15.07 13.61  
P/L Before Int., Excpt. Items & Tax 222.85 140.84 273.51 323.59 357.63  
Interest 6.79 3.21 1.27 1.47 1.26  
P/L Before Exceptional Items & Tax 216.06 137.63 272.24 322.12 356.37  
Exceptional Items -- -- -- -- --  
P/L Before Tax 216.06 137.63 272.24 322.12 356.37  
Tax 72.24 27.22 54.07 64.48 71.65  
P/L After Tax from Ordinary Activities 143.82 110.41 218.17 257.64 284.72  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 143.82 110.41 218.17 257.64 284.72  
Equity Share Capital 25.37 25.37 25.37 25.37 25.37  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 5.67 4.35 8.60 20.31 22.45  
Diluted EPS 5.67 4.35 8.60 20.31 22.45  
EPS After Extra Ordinary  
Basic EPS. 5.67 4.35 8.60 20.31 22.45  
Diluted EPS. 5.67 4.35 8.60 20.31 22.45  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited